A six-point patient protection plan developed in January 2010.

Over the past year, ASTRO offers: Related StoriesViralytics enters into medical trial collaboration contract with MSDNew RNA check of blood platelets may be used to detect location of cancerNew findings reveal association between colorectal cancer and melanoma drug treatmentProposed federal legislation to build up a national medical mistake reporting system and a patient safety data source for radiation oncology. Tested the compatibility of different radiation oncology equipment vendors.The intention-to-treat analyses included maternal outcomes from receipt of vaccine or placebo to 175 days after birth and infant outcomes from birth to 175 days of age. The per-process immunogenicity evaluation was limited to ladies from whom a bloodstream sample was obtained 28 to 35 times after vaccination and to infants from whom a blood sample was acquired within seven days after birth and who acquired a gestational age group of at least 37 weeks at birth or a birth excess weight of at least 2500 g. An exploratory analysis was performed by using extended windows for obtaining bloodstream samples after vaccination and after delivery . Research data were collected and managed by using Research Electronic Data Catch , version All statistical analyses were carried out by using Stata software, version 12.1.